SE184573C1 - - Google Patents

Info

Publication number

SE184573C1

SE184573C1 SE184573DA SE184573C1 SE 184573 C1 SE184573 C1 SE 184573C1 SE 184573D A SE184573D A SE 184573DA SE 184573 C1 SE184573 C1 SE 184573C1

Authority

SE

Sweden

Prior art keywords

line

circuit

pulse

connection

information

Prior art date

1963-01-01

Links

• Espacenet
• Global Dossier
• Discuss

• 238000009826 distribution Methods 0.000 claims description 107
• 230000008878 coupling Effects 0.000 claims description 75
• 238000010168 coupling process Methods 0.000 claims description 75
• 238000005859 coupling reaction Methods 0.000 claims description 75
• 238000002360 preparation method Methods 0.000 claims description 56
• 238000003860 storage Methods 0.000 claims description 46
• 230000010349 pulsation Effects 0.000 claims description 45
• 230000006870 function Effects 0.000 claims description 25
• 230000005415 magnetization Effects 0.000 claims description 25
• 230000005540 biological transmission Effects 0.000 claims description 23
• 230000004044 response Effects 0.000 claims description 22
• 230000008859 change Effects 0.000 claims description 16
• 230000004913 activation Effects 0.000 claims description 15
• 150000003839 salts Chemical class 0.000 claims description 15
• 238000000034 method Methods 0.000 claims description 14
• 230000008569 process Effects 0.000 claims description 10
• 230000000694 effects Effects 0.000 claims description 9
• 239000004020 conductor Substances 0.000 claims description 8
• 238000001514 detection method Methods 0.000 claims description 6
• 238000011084 recovery Methods 0.000 claims description 6
• 238000006073 displacement reaction Methods 0.000 claims description 4
• RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 claims description 3
• 229910052719 titanium Inorganic materials 0.000 claims description 3
• 239000010936 titanium Substances 0.000 claims description 3
• 238000012546 transfer Methods 0.000 claims description 2
• 238000009434 installation Methods 0.000 claims 3
• PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims 1
• 230000015572 biosynthetic process Effects 0.000 claims 1
• 230000005284 excitation Effects 0.000 claims 1
• 230000002123 temporal effect Effects 0.000 claims 1
• 210000004027 cell Anatomy 0.000 description 81
• 230000011664 signaling Effects 0.000 description 69
• 230000015654 memory Effects 0.000 description 38
• 239000011505 plaster Substances 0.000 description 25
• 239000011159 matrix material Substances 0.000 description 24
• 238000010586 diagram Methods 0.000 description 20
• 238000009825 accumulation Methods 0.000 description 19
• 210000002325 somatostatin-secreting cell Anatomy 0.000 description 15
• 239000003550 marker Substances 0.000 description 14
• 239000008186 active pharmaceutical agent Substances 0.000 description 13
• 239000006187 pill Substances 0.000 description 12
• 239000003990 capacitor Substances 0.000 description 9
• 230000000903 blocking effect Effects 0.000 description 8
• 230000009471 action Effects 0.000 description 7
• 230000008901 benefit Effects 0.000 description 7
• 238000006243 chemical reaction Methods 0.000 description 7
• 239000013256 coordination polymer Substances 0.000 description 6
• 230000005032 impulse control Effects 0.000 description 6
• 230000003068 static effect Effects 0.000 description 6
• 230000001360 synchronised effect Effects 0.000 description 6
• 238000012217 deletion Methods 0.000 description 5
• 230000037430 deletion Effects 0.000 description 5
• 210000003719 b-lymphocyte Anatomy 0.000 description 4
• 238000012544 monitoring process Methods 0.000 description 4
• 238000003825 pressing Methods 0.000 description 4
• 239000002956 ash Substances 0.000 description 3
• 238000004140 cleaning Methods 0.000 description 3
• 230000003111 delayed effect Effects 0.000 description 3
• 239000010410 layer Substances 0.000 description 3
• 238000002161 passivation Methods 0.000 description 3
• 238000012545 processing Methods 0.000 description 3
• 230000002250 progressing effect Effects 0.000 description 3
• 241000234427 Asparagus Species 0.000 description 2
• 235000005340 Asparagus officinalis Nutrition 0.000 description 2
• 210000004128 D cell Anatomy 0.000 description 2
• 235000002918 Fraxinus excelsior Nutrition 0.000 description 2
• 210000001744 T-lymphocyte Anatomy 0.000 description 2
• DTTPWCNKTMQMTE-TYNNPWLESA-N [(1R,2S,3S,4S,5R,6S,8R,12S,13S,16R,19S,20R,21S)-14-ethyl-2-hydroxy-4,6,19-trimethoxy-16-methyl-9,11-dioxa-14-azaheptacyclo[10.7.2.12,5.01,13.03,8.08,12.016,20]docosan-21-yl] acetate Chemical compound CCN1C[C@]2(C)CC[C@H](OC)[C@]34[C@@H]2[C@H](OC(C)=O)[C@@]2(OCO[C@@]22C[C@H](OC)[C@H]5C[C@]3(O)[C@@H]2[C@H]5OC)[C@@H]14 DTTPWCNKTMQMTE-TYNNPWLESA-N 0.000 description 2
• 230000003213 activating effect Effects 0.000 description 2
• 238000003776 cleavage reaction Methods 0.000 description 2
• 238000005520 cutting process Methods 0.000 description 2
• DTTPWCNKTMQMTE-UHFFFAOYSA-N delphelatine Natural products O1COC2(C3C4OC)CC(OC)C4CC3(O)C34C(OC)CCC5(C)CN(CC)C4C21C(OC(C)=O)C53 DTTPWCNKTMQMTE-UHFFFAOYSA-N 0.000 description 2
• WNIGHBYIOLQQSJ-UHFFFAOYSA-N deltaline Natural products CCN1CC2(COC)CCC(O)C34C2C(OC(=O)C)C5(OCOC56CC(OC)C7CC3(O)C6C7O)C14 WNIGHBYIOLQQSJ-UHFFFAOYSA-N 0.000 description 2
• 230000008034 disappearance Effects 0.000 description 2
• 230000000977 initiatory effect Effects 0.000 description 2
• 230000003993 interaction Effects 0.000 description 2
• 230000006855 networking Effects 0.000 description 2
• 239000008188 pellet Substances 0.000 description 2
• 238000012552 review Methods 0.000 description 2
• 230000007017 scission Effects 0.000 description 2
• 238000009987 spinning Methods 0.000 description 2
• 238000004448 titration Methods 0.000 description 2
• 241000046053 Betta Species 0.000 description 1
• 241000630665 Hada Species 0.000 description 1
• 241001397173 Kali <angiosperm> Species 0.000 description 1
• 101100004031 Mus musculus Aven gene Proteins 0.000 description 1
• 102100035593 POU domain, class 2, transcription factor 1 Human genes 0.000 description 1
• 101710084414 POU domain, class 2, transcription factor 1 Proteins 0.000 description 1
• 230000006978 adaptation Effects 0.000 description 1
• 210000000941 bile Anatomy 0.000 description 1
• 239000011230 binding agent Substances 0.000 description 1
• 239000011248 coating agent Substances 0.000 description 1
• 238000000576 coating method Methods 0.000 description 1
• 238000010276 construction Methods 0.000 description 1
• 230000036461 convulsion Effects 0.000 description 1
• 238000012937 correction Methods 0.000 description 1
• 230000001419 dependent effect Effects 0.000 description 1
• 238000005538 encapsulation Methods 0.000 description 1
• 230000005283 ground state Effects 0.000 description 1
• 230000002650 habitual effect Effects 0.000 description 1
• 230000006698 induction Effects 0.000 description 1
• 238000007689 inspection Methods 0.000 description 1
• 241000238565 lobster Species 0.000 description 1
• 239000000696 magnetic material Substances 0.000 description 1
• 238000012423 maintenance Methods 0.000 description 1
• 230000007257 malfunction Effects 0.000 description 1
• 239000000463 material Substances 0.000 description 1
• 230000013011 mating Effects 0.000 description 1
• 230000006386 memory function Effects 0.000 description 1
• 230000003278 mimic effect Effects 0.000 description 1
• 239000013642 negative control Substances 0.000 description 1
• 230000000737 periodic effect Effects 0.000 description 1
• 230000002093 peripheral effect Effects 0.000 description 1
• 230000002028 premature Effects 0.000 description 1
• 230000000717 retained effect Effects 0.000 description 1
• 238000010615 ring circuit Methods 0.000 description 1
• 235000002020 sage Nutrition 0.000 description 1
• 208000011726 slow pulse Diseases 0.000 description 1
• 235000015096 spirit Nutrition 0.000 description 1
• 239000007858 starting material Substances 0.000 description 1
• 239000002344 surface layer Substances 0.000 description 1
• 230000009466 transformation Effects 0.000 description 1
• 230000007704 transition Effects 0.000 description 1
• 229940070710 valerate Drugs 0.000 description 1
• NQPDZGIKBAWPEJ-UHFFFAOYSA-N valeric acid Chemical compound CCCCC(O)=O NQPDZGIKBAWPEJ-UHFFFAOYSA-N 0.000 description 1
• 238000004018 waxing Methods 0.000 description 1
• 238000003466 welding Methods 0.000 description 1